Suchergebnisse - "Jones, Aksana"

PubPharm (25)

1

Sputum lipoarabinomannan (LAM) as a biomarker to determine sputum mycobacterial load : exploratory and model-based analyses of integrated data from four cohorts

enthalten in: BMC infectious diseases | 2022

von Jones, A. | Saini, J. | Kriel, B. | +12

2

Sputum lipoarabinomannan (LAM) as a biomarker to determine sputum mycobacterial load: exploratory and model-based analyses of integrated data from four cohorts

enthalten in: BMC infectious diseases | 2022

von Jones, A. | Saini, J. | Kriel, B. | +12

3

Sputum lipoarabinomannan (LAM) as a biomarker to determine sputum mycobacterial load: exploratory and model-based analyses of integrated data from four cohorts

enthalten in: BMC infectious diseases | 2022

von Jones, A. | Saini, J. | Kriel, B. | +12

4

Dose selection for fremanezumab (AJOVY) phase 3 pediatric migraine studies using pharmacokinetic data from a pediatric phase 1 study and a population pharmacokinetic modeling and simulation approach

enthalten in: Cephalalgia : an international journal of headache | 2021

von Cohen-Barak, O. | Radivojevic, A. | Jones, A. | +12

5

Scaling Approaches for Pediatric Dose Selection : The Fremanezumab (AJOVY®) Journey to Select a Phase 3 Dose Using Pharmacokinetic Data from a Phase 1 Study

enthalten in: Pharmaceutics | 2021

von Jones, A. | Cohen-Barak, O. | Radivojevic, A. | +1

6

Population Pharmacokinetics of a Monthly Buprenorphine Depot Injection for the Treatment of Opioid Use Disorder : A Combined Analysis of Phase II and Phase III Trials

enthalten in: Clinical pharmacokinetics | 2021

von Jones, A. | Ngaimisi, E. | Gopalakrishnan, M. | +2

7

Population Pharmacokinetics of a Monthly Buprenorphine Depot Injection for the Treatment of Opioid Use Disorder: A Combined Analysis of Phase II and Phase III Trials

enthalten in: Clinical pharmacokinetics | 2020

von Jones, A. | Ngaimisi, E. | Gopalakrishnan, M. | +2

8

Population Pharmacokinetics of a Monthly Buprenorphine Depot Injection for the Treatment of Opioid Use Disorder: A Combined Analysis of Phase II and Phase III Trials

enthalten in: Clinical pharmacokinetics | 2020

von Jones, A. | Ngaimisi, E. | Gopalakrishnan, M. | +2

9

Population Pharmacokinetics of a Monthly Buprenorphine Depot Injection for the Treatment of Opioid Use Disorder: A Combined Analysis of Phase II and Phase III Trials

enthalten in: Clinical pharmacokinetics | 2020

von Jones, A. | Ngaimisi, E. | Gopalakrishnan, M. | +2

10

Population Pharmacokinetics of Clofarabine as Part of Pretransplantation Conditioning in Pediatric Subjects before Hematopoietic Cell Transplantation

enthalten in: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation | 2019

von Wang, H. | Jones, A. | Dvorak, C. | +4